Received: from AM7PR02MB6259.eurprd02.prod.outlook.com (2603:10a6:20b:1bd::11) by DB9PR02MB7817.eurprd02.prod.outlook.com with HTTPS; Tue, 9 Jun 2026 07:04:09 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com (2603:10a6:150:318::18) by AM7PR02MB6259.eurprd02.prod.outlook.com (2603:10a6:20b:1bd::11) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.92.14; Tue, 9 Jun 2026 07:04:08 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f]) by GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f%2]) with mapi id 15.21.0092.011; Tue, 9 Jun 2026 07:04:08 +0000 From: "Andrus Varki - RA" To: "Info - SOM" Cc: =?utf-8?Q?Keiu_P=C3=B5derson_-_RA?= , "Mari Amos - SOM" References: <0b1142f2de5b4ee9b77a206ee9671966@ravimiamet.ee> In-Reply-To: Subject: =?utf-8?Q?Ed:_Eeln=C3=B5u_edastamine_koosk=C3=B5last?= =?utf-8?Q?amiseks_ja_arvamuse_avaldamiseks?= Date: Tue, 9 Jun 2026 10:04:08 +0300 Keywords: Mall Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0027_01DCF80D.8D78F4D0" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQIOkpl4/ke9+WNmGnvinYgaN9pG2wEidV1AAvAO1mEBgZBMcA== Authentication-Results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 09 Jun 2026 07:04:08.9610 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: ff618e40-01c9-4e6a-5027-08dec5f54d32 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GVXPR02MB12202:EE_|AM7PR02MB6259:EE_|DB9PR02MB7817:EE_ X-MS-Exchange-Organization-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: ff618e40-01c9-4e6a-5027-08dec5f54d32 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|366016|31052699007|39142699007|55112099003|11063799006|4143699003|56012099006|22082099003|18002099003|13003099007|8096899003|41050700001; X-Forefront-Antispam-Report: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GVXPR02MB12202.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(366016)(31052699007)(39142699007)(55112099003)(11063799006)(4143699003)(56012099006)(22082099003)(18002099003)(13003099007)(8096899003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 09 Jun 2026 07:04:08.5503 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: ff618e40-01c9-4e6a-5027-08dec5f54d32 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted X-MS-Exchange-Transport-CrossTenantHeadersStamped: AM7PR02MB6259 X-MS-Exchange-Transport-EndToEndLatency: 00:00:01.4343680 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0092.005 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 Content-Language: et x-ms-exchange-organization-originalclientipaddress: 45.156.32.7 x-ms-exchange-organization-originalserveripaddress: 2603:10a6:150:318::18 X-OlkEid: 00000000D07AAE8E23CDBE4CA04D01CCD82FCB7E070034AD76187591974DBF6C4F76951C873A01000200000000005797C783AAECB34FA6C879FF487E64D9000000000D5A0000B747F770B92AE947A031F47F38AB9A59 X-MS-Has-Attach: X-MS-TNEF-Correlator: acceptlanguage: et-EE, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-06-09T07:04:07.875Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; x-codetwoprocessed: true x-codetwo-clientsignature-inserted: true X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-CrossTenant-MailboxType: HOSTED X-MS-Exchange-CrossTenant-UserPrincipalName: On7xgaCLBmVv816mORlo4uBrjNfGm4lQ5ElVBWNaU9CL8pCT2sJSNiYZaSnGdAEmoZ058MkzU8dKH6C1INf1VzMcPI/RqOiCZw2aI/6Ab/I= This is a multipart message in MIME format. ------=_NextPart_000_0027_01DCF80D.8D78F4D0 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Teie:    28.05.2026 nr 1.2-3/1377-1 Meie:   09.06.2026 nr JUR-3/3058-2 Tere Ravimiametil ei ole tähelepanekuid eelnõule. Lugupidamisega Andrus Varki juhataja Õigusosakond Ravimiamet 737 4140 www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. ------=_NextPart_000_0027_01DCF80D.8D78F4D0 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable
Teie:=E2=80=82=E2=80=82=E2=80=82=E2=80=8228.05.2026 nr = 1.2-3/1377-1
Meie:=E2=80=82=E2=80=82=E2=80=8209.06.2026 nr JUR-3/3058-2


Tere

Ravimiametil ei ole t=C3=A4helepanekuid eeln=C3=B5ule. 


Lugupidamisega

Andrus Varki

juhataja

=C3=95igusosakond


Ravimiamet

737 4140

www.ravimiamet.ee


Selles = e-kirjas sisalduv teave (kaasa arvatud manused) on m=C3=B5eldud = ametialaseks kasutamiseks ning seda v=C3=B5ivad kasutada vaid e-kirja = adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt = v=C3=A4ljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. = Juhul, kui Te olete saanud k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, = teavitage sellest koheselt saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 



 

------=_NextPart_000_0027_01DCF80D.8D78F4D0--